Clinical Trial

Groningen International Study on Sentinel Nodes in Vulvar Cancer-III

Name: Groningen International Study on Sentinel Nodes in Vulvar Cancer-III — clinical trial record (NCT05076942)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: GROINSS-VIII

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

Vulvar cancer patients with SN-metastasis \> 2mm will receive chemoradiation instead of an inguinofemoral lymphadenectomy.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2021-10-01.

Trial Details

NCT Number	NCT05076942
Lead Sponsor	University Medical Center Groningen Collaborators: Dutch Cancer Society, NRG Oncology
Conditions	Vulvar Cancer, Sentinel Lymph Node, Lymph Node Metastases
Enrollment	157 participants
Start Date	2021-01-01
Primary Completion	2028-01-01 (estimated)
Study Completion	2029-01-01 (estimated)
Updated on ClinicalTrials.gov	2023-08-01